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Summary  
 
A systematic review of the literature about patients’ preferences for 
involvement in cancer treatment decision making was conducted. 
Establishing preferences is important if the aim is to make health care 
more sensitive to the needs and expectations of each individual 
patient. Thirty-one papers were included in the review. Generalising 
from this literature is problematic because of limitations related to 
sample size, sample composition and methods used to assess 
preferences. Whilst we take cognizance of these limitations, research 
suggests that preferences vary considerably and that whilst most 
patients prefer a collaborative role, a significant minority prefer a 
passive or active role. Evidence about the association of factors such 
as age, gender, level of education, marital status, socioeconomic 
status and health status with preferences is inconclusive. Only a 
handful of studies investigated the degree of congruence between 
patients’ role preferences and the actual role that they perceived they 
had played, which highlight that some patients experience a 
dissonance between the two. Similarly, few studies investigated the 
impact of this dissonance on patient anxiety or satisfaction with the 
treatment decision. We advocate more rigorous investigations before 
recommendations for health care professionals can be processed with 
confidence.  
 
Keywords: Decision making; Treatment; Cancer; Involvement 
 
Introduction  
Health and social care policy promotes the agenda of involvement by 
encouraging patients, careers and members of the public to adopt a greater 
level of responsibility for and participation in health care, including, playing a 
much greater role in decisions affecting their own treatment and care 
(Department of Health, 2003). Medical ethics has emphasised the right of 
patients to be fully informed and to participate in treatment decision making, 
which is legislated for in some countries (Guadagnoli and Ward, 1998). The 
recent emphasis on patient involvement and autonomy in health care 
settings is indicative of efforts to promote a move away from a paternalistic 
form of care towards one of partnership between the medical profession and 
patients. This, in turn, reflects wider cultural tendencies that position patients 
as active consumers and citizens involved in making health care decisions.  
There is a wealth of evidence related to treatment decision making for 
patients with cancer. This includes a significant amount of research about the 
use of decision aids (Caress, 2000) to facilitate decision making, but also a 
small but growing amount of literature related to other aspects of treatment 
decision making including research about the influence of patient 
involvement in treatment decision making on quality of life (Andersen and 
Urban, 1999), the impact of the media on treatment decision making 
(Passalacqu et al., 2004), the relationship of depression and anxiety to 
treatment decision making (Petersen et al., 2003), how married couples 
interact in reaching a treatment decision (Boehmer and Clark, 2001), 
patients’ attitudes towards different treatment options (Brundage et al., 
2001), decisional regret (Davison and Goldenberg, 2003), decision making in 
palliative care treatment (De Haes and Koedoot, 2003) and preferences for 
different types of treatment (Soloman et al., 2003).  
Researchers have also investigated patients’ preferences for involvement in 
treatment decision making. Establishing preferences for involvement in 
treatment decision making is important if the aim is to make health care 
more sensitive to the needs and expectations of each individual patient. 
Since patients are not a homogenous group, it cannot be assumed that they 
will all want to play an active or collaborative role in making decisions about 
their care. Thus, a shared decision-making process with doctors and patients 
involved in treatment decision making may be too simplistic of a model. This 
is why the process of health care professionals systematically finding out 
about patient preferences in relation to involvement in treatment decision 
making is seen as crucial.  
As part of a larger systematic review of literature about the agenda of 
involvement in cancer care, a review of research about patients’ preferences 
for involvement in treatment decision making was conducted (Hubbard et al., 
2007). The review aimed to improve understanding of the role that patients 
with cancer want in relation to their treatment decision making, socio-
demographic factors that influence role preference, the degree of congruence 
between patients’ preferred and actual roles in treatment decision making, 
and the impact of role preferences on outcomes, such as patient satisfaction.  
Methods  
Type of review  
This review was carried out using systematic methods to produce a narrative 
summary. We used systematic methods to search for literature, applied 
inclusion and exclusion criteria, appraised the quality of studies included, 
selected relevant data from the included studies for analysis and provided a 
narrative summary of these data.  
Searching for literature  
All database searches ran from 1994 to 2004 inclusive. No language, 
geographical or methodological limits, was imposed on the results. The 
majority of hits were contained within the major and best-known health 
databases: AMED (Allied and Complementary Medicine), CINAHL, EMBASE, 
Evidence Based Medicine Reviews (Cochrane DSR, ACP Journal Club, DARE 
and CCTR), HMIC (Health Management Information Consortium), Medline 
and PsychINFO. A broad search including subject headings of the terms 
‘decision’ (for example, decision making, choice, decision and decisional) and 
‘cancer’ (for example, oncology, neoplasm and tumour) was employed. A 
cited reference search and free test searches were also conducted.  
Inclusion and exclusion of documents  
The 279 papers were examined for potential inclusion in the review. Two 
members of the review team read abstracts and decided which papers to 
include in the review. Only research studies or reviews of literature about 
preferences for involvement in treatment decision making for cancer were 
included. Papers were included even if preferences for involvement in 
treatment decision making were only a part of the study. For example, if the 
study was also about preferences for information but contained findings on 
preferences for involvement in treatment decision making, it was included. 
Papers about role preferences for decision making about screening for cancer 
or genetic testing were not included because the focus of the review was on 
decisions related to treatment. Papers were included if the sample also 
included other groups of the population, such as patients with different 
diseases in addition to patients with a diagnosis of cancer, or groups of 
people that were related to patients with cancer for example, parents. There 
is a vast amount of literature about treatment decision making and the 
majority of papers excluded from the review were those that were about 
decision-making aids.  
Quality appraisal  
Quality appraisal was conducted for all documents using the same criteria 
developed by Dixon Woods et al. (2005), as shown in Box 1. Their criterion 
judges a paper on the clarity and explication of the aims and objectives of 
the study, study design, methods and findings. Documents were rated 5 if all 
aspects of the study were clear, 4 if the method or analysis or sample were 
not clearly outlined or 3 if both the method or analysis and sample were 




Data analysis  
One member of the review team extracted narrative data from each paper. 
Only narrative data related to preferences for involvement in treatment 
decision making, the factors that influence these preferences, the impact of 
preferences for involvement in treatment decision making on patient 
outcomes and the degree of congruence between patients’ preferred and 
perceived actual role was extracted. Extracted narrative data were compared 
across each of the papers to identify key issues and summarise key points.  
Another member of the team read the papers to confirm that relevant 
narrative data had been extracted.  
Results  
A total of 31 papers were included (26 from electronic database searches and 
5 from cited references or journal searches), all of which received the highest 
quality appraisal rating. No literature reviews were found, thus all papers 
included in the review are research studies. Table 1 summarises the method 
employed, sample chosen and the key findings for each paper.  
Methods and sample  
The 31 papers were compared by method and sample. The overwhelming 















a preferences scale (Hack et al., 1994; Davison et al., 1995; Barry and 
Henderson, 1996; Beaver et al., 1996; Bilodeau and Degner, 1996; Butow et 
al., 1997; Degner et al., 1997; Rothenbacher et al., 1997; Stigglebout and 
Kiebert, 1997; Beaver et al., 1999; Davidson et al., 1999; Pyke Grimm et al., 
1999; Wallberg et al., 2000; Wong et al., 2000; Bruera et al., 2001; 
Gattellari et al., 2001; Lobb et al., 2001; Bruera et al., 2002; Davison et al., 
2002; Keating et al., 2002; Gagnon and Recklitis, 2003; Heyland et al., 
2003; Davison et al., 2004; Janz et al., 2004), the overwhelming majority of 
which used the preferences scale developed by Degner and Sloan (1992), as 
shown in Box 2.  
 This scale categorises patients into one of three roles depending on the 
extent of their preferred involvement in treatment decision making:  
• Active, where the patient themselves decides on which would be the 
most appropriate treatment option for themselves.  
• Collaborative (sometimes described as shared), where the 
patient and the doctor jointly decide on the most appropriate 
treatment option and  
• Passive, where the patient leaves the decision on themost 
appropriate treatment option to the doctor.  
 
Most studies only included small numbers of patients and it was not 
possible from reading the paper to deduce whether or not these were 
representative of a larger population. Only nine studies recruited a patient 
group of 150 or more (Beisecker et al., 1994; Beaver et al., 1996; Degner et 
al., 1997; Petrisek et al., 1997; Wallberg et al., 2000; Gattellari et al., 2001; 
Keating et al., 2002; Beaver et al., 2003; Kraetschmer et al., 2004). The 
overwhelming majority of studies included adults and focused on adult 
preferences for involvement in treatment decision making.  
 
 One study elicited the preferences of teenagers and young adults (Dunsmore 
and Quine, 1995), one study focussed on the preferences of paediatric 
oncology patients (Gagnon and Recklitis, 2003) and one study focussed on 
the preferences of parents of paediatric oncology patients (Pyke Grimm et 
al., 1999).  
 
Samples varied considerably by cancer type (Table 2). Most studies 
focussed exclusively on women with breast cancer (12 in total) (Beisecker et 
al., 1994; Hack et al., 1994; Beaver et al., 1996; Bilodeau and Degner, 
1996; Johnson et al., 1996; Degner et al., 1997; Petrisek et al., 1997; 
Wallberg et al., 2000; Lobb et al., 2001; Bruera et al., 2002; Keating et al., 
2002; Janz et al., 2004). One of these studies did not actually focus on a 
sample of patients with cancer but on the perceptions of oncologists, 
oncology nurses and patients attending a women’s clinic (Beisecker et al., 
1994). Most other studies focussed on a heterogeneous patient group with a 
mix of different cancers (11 in total) (Dunsmore and Quine, 1995; Barry and 
Henderson, 1996; Butow et al., 1997; Rothenbacher et al., 1997; Stigglebout 
and Kiebert, 1997; Pyke Grimm et al., 1999; Bruera et al., 2001; Gattellari 
et al., 2001; Gagnon and Recklitis, 2003; Heyland et al., 2003; Kraetschmer 
et al., 2004). One of these studies focussed on the parents of paediatric 
oncology patients with heterogeneous cancers (Pyke Grimm et al., 1999). 
Four studies focussed on patients with prostate cancer (Davison et al., 1995; 
Wong et al., 2000; Davisonet al.,2002; Davison et al., 2004) with one study 
focussingonpatientswithprostatecancerpre-diagnosis (Davison et al., 2004). 
Two studies focussed on patients with colorectal cancer (Beaver et al., 1999, 
2003), whilst one study focussed on patients with lung cancer (Davidson et 
al., 1999).  
 
Study samples varied by time since diagnosis (Table 3). Nine studies 
included patients who had been newly diagnosed or were in the first six 
months post-diagnosis (Hack et al., 1994; Beaver et al., 1996; Bilodeau and 
Degner, 1996; Johnson et al., 1996; Lobb et al., 2001; Bruera et al., 2002; 
Davison et al., 2002; Keating et al., 2002; Janz et al., 2004), five studies 
included patients who were reaching 1–2 years post-diagnosis (Petrisek et 
al., 1997; Pyke Grimm et al., 1999; Wallberg et al., 2000; Gattellari et al., 
2001; Gagnon and Recklitis, 2003) and four studies investigated the 
preferences of palliative patients (Barry and Henderson, 1996; Rothenbacher 
et al., 1997; Bruera et al., 2001; Heyland et al., 2003). It was difficult to 
identify the time since diagnosis in 13 of the remaining studies since the 
sample either comprised a mix of different stages of cancer (Dunsmore and 
Quine, 1995; Beaver et al., 1996; Degner et al., 1997; Beaver et al., 1999; 
Wong et al., 2000; Beaver et al., 2003) or were unclear (Butow et al., 1997; 
Stigglebout and Kiebert, 1997; Davidson et al., 1999; Davison et al., 2002; 
Kraetschmer et al., 2004). The time since diagnosis was not relevant in two 
studies (Beisecker et al., 1994; Davison et al., 2004).  
 
Preferences for involvement in treatment decision making  
A total of 20 studies used Degner and Sloan (1992) (Box 2) preferences scale 
to categorise patients’ preferences for adopting an active, passive or 
collaborative role in treatment decision making. In 11 of these studies, 
involving a range of patients with different cancer types and at different 
stages following diagnosis (including children and patients in the palliative 
stages of care), the majority of patients clearly expressed a preference for a 
collaborative role in treatment decision making (Hack et al., 1994; Degner et 
al., 1997; Rothenbacher et al., 1997; Wallberg et al., 2000; Bruera et al., 
2001; Gattellari et al., 2001; Bruera et al., 2002; Gagnon and Recklitis, 
2003; Heyland et al., 2003; Davison et al., 2004; Janz et al., 2004). In six 
studies, the majority of patients expressed a preference for a passive role 
(Bilodeau and Degner, 1996; Butow et al., 1997; Beaver et al., 1999; 
Davidson et al., 1999; Pyke Grimm et al., 1999; Hinds et al., 2000). These 
studies involved patients with a diagnosis of breast, lung, colorectal or 
prostate cancer at different stages following diagnosis. Beaver et al. (1996, 
1999) identified that although both patients with breast or colorectal cancers 
in these studies expressed a predominant preference for a passive role, more 
patients in the colorectal cancer group were likely to prefer a passive role 
than those in the breast cancer patient group. In a later study amongst 
patients with colorectal cancer only (n =375); however, Beaver et al. (2003) 
identified that a greater number of patients expressed a preference for a 
collaborative role in treatment decision making. One study of parents of 
paediatric oncology patients found that the majority of parents preferred a 
collaborative role (Pyke Grimm et al., 1999). There were only three studies in 
which the majority of patients expressed a preference for an active role in 
treatment decision making (Barry and Henderson, 1996; Stigglebout and 
Kiebert, 1997; Davison et al., 2002).  
Factors affecting patients’ preferences for involvement  
A number of studies have researched the associations between patients’ 
preferences for involvement in treatment decision making and age (16 in 
total) (Beisecker et al., 1994; Hack et al., 1994; Davison et al., 1995; 
Beaver et al., 1996; Bilodeau and Degner, 1996; Butow et al., 1997; Degner 
et al., 1997; Petrisek et al., 1997; Rothenbacher et al., 1997; Pyke Grimm et 
al., 1999; Wong et al., 2000; Lobb et al., 2001; Bruera et al., 2002; Beaver 
et al., 2003; Heyland et al., 2003; Davison et al., 2004), gender (4 in total) 
(Butow et al., 1997; Rothenbacher et al., 1997; Pyke Grimm et al., 1999; 
Beaver et al., 2003), race/ethnicity (2 in total) (Degner et al., 1997; Bruera 
et al., 2002), level of education (15 in total) (Hack et al., 1994; Beaver et 
al., 1996; Davison et al., 1995; Degner et al., 1997; Rothenbacher et al., 
1997; Stigglebout and Kiebert, 1997; Pyke Grimm et al., 1999; Lobb et al., 
2001; Wallberg et al., 2000; Wong et al., 2000; Bruera et al., 2002; Gagnon 
and Recklitis, 2003; Heyland et al., 2003; Davison et al., 2004; Janz et al., 
2004), marital status (12 in total) (Davison et al., 1995; Butow et al., 1997; 
Degner et al., 1997; Rothenbacher et al., 1997; Beaver et al., 1999; Pyke 
Grimm et al., 1999; Wallberg et al., 2000; Lobb et al., 2001; Bruera et al., 
2002; Heyland et al., 2003; Davison et al., 2004; Janz et al., 2004), 
employment status (5 in total) (Rothenbacher et al., 1997; Lobb et al., 2001; 
Bruera et al., 2002; Heyland et al., 2003; Janz et al., 2004), socioeconomic 
status (2 in total) (Beaver et al., 1996, 2003), level of income (3 in total) 
(Bruera et al., 2002; Gagnon and Recklitis, 2003; Janz et al., 2004), type or 
stage of cancer (3 in total) (Davison et al., 1995; Wong et al., 2000; Bruera 
et al., 2002) and patients’ health status (5 in total) (Barry and Henderson, 
1996; Butow et al., 1997; Hinds et al., 2000; Wong et al., 2000; Bruera et 
al., 2002). These findings are summarised in Table 1.  
 
Briefly, 11 studies did not identify an association between age and role 
preferences (Beisecker et al., 1994; Hack et al., 1994; Davison et al., 1995; 
Butow et al., 1997; Pyke Grimm et al., 1999; Wong et al., 2000; Bruera et 
al., 2002; Beaver et al., 2003; Heyland et al., 2003; Davison et al., 2004; 
Janz et al., 2004). Five studies, however, including three studies involving 
patients with breast cancer and one study involving patients receiving 
palliative care, reported that younger people were more likely to prefer a 
collaborative or active role in decision making (Beaver et al., 1996; Bilodeau 
and Degner, 1996; Degner et al., 1997; Rothenbacher et al., 1997; Lobb et 
al., 2001). In contrast, one study including 76 women with breast cancer 
reported that younger women were more likely to want their doctors to make 
a recommendation (Johnson et al., 1996). Three studies reported no 
association between gender and role preference (Butow et al., 1997; 
Rothenbacher et al., 1997; Pyke Grimm et al., 1999), whereas one study 
found that women were more likely to prefer an active role (Beaver et al., 
2003). There were no studies which identified an association between 
race/ethnicity and role preference (Degner et al., 1997; Bruera et al., 2002) 
and between level of income and role preference (Bruera et al., 2002; 
Gagnon and Recklitis, 2003; Janz et al., 2004). One study reported an 
association between employment status and role preference, with employed 
patients wishing a more active role in their treatment decision making 
(Rothenbacher et al., 1997). A total of six studies, primarily involving 
patients diagnosed with breast cancer, have reported an association between 
level of education and role preference, finding that those with a higher level 
of education prefer a collaborative or active role in their treatment decision 
making (Hack et al., 1994; Beaver et al., 1996; Degner et al., 1997; 
Rothenbacher et al., 1997; Wallberg et al., 2000; Janz et al., 2004). On the 
other hand, eight studies have reported no such association between 
education and role preference (Davison et al., 1995; Wong et al., 2000; 
Bruera et al., 2002; Stigglebout and Kiebert, 1997; Keating et al., 2002; 
Gagnon and Recklitis, 2003; Heyland et al., 2003; Davison et al., 2004).  
 
Marital status was found to be associated with role preference in eight 
studies, with married people being more likely to prefer an active role in their 
treatment decision making (Davison et al., 1995; Butow et al., 1997; 
Rothenbacher et al., 1997; Wong et al., 2000; Lobb et al., 2001; Bruera et 
al., 2002; Heyland et al., 2003; Janz et al., 2004). These studies included a 
range of patients with different cancer types, such as breast and prostate 
cancer, and at different stages in their cancer journey, including those newly 
diagnosed, to those in the palliative stages of their disease. Four studies, 
including one involving more than 1000 women with breast cancer (Degner 
et al., 1997) did not identify an association between martial status and role 
preference (Beaver et al., 1996; Pyke Grimm et al., 1999; Davison et al., 
2004). Two studies, in patients with breast or colorectal cancers, investigated 
the association between socioeconomic status and role preference (Beaver et 
al., 1996, 2003). Whilst the study in patients with breast cancer (Beaver et 
al., 1996) identified that lower socioeconomic status was associated with a 
passive role, there was no such association found amongst patients with 
colorectal cancer (Beaver et al., 2003).  
 
Three studies investigated the association between patients’ type or stage 
of cancer and role preference, but found no association (Davison et al., 
1995; Wong et al., 2000; Bruera et al., 2002). Three studies noted an 
association between declining health status or the experience of cancer-
related side effects and role preference (Barry and Henderson, 1996; Butow 
et al., 1997; Hinds et al., 2000). One study (Butow et al., 1997) found that 
patients whose condition had recently worsened were more likely to want 
progressively less involvement in decision making, whilst another small-scale 
study (Barry and Henderson, 1996)(n =7) found that patients whose 
conditioned had worsened were more likely to prefer an active role in 
decision making. A team of researchers (Hinds et al., 2000) who investigated 
the preferences of patients in the palliative stages of their disease reported 
that nausea and the effect of fatigue on the ability of the patient to recall 
events, were significantly related to role preference, with more patients 
preferring a passive role. Two studies reported no association between health 
status and role preference (Wong et al., 2000; Bruera et al., 2002).  
Degree of congruence between role preference  
A total of eight studies investigated the degree of congruence between 
patients’ role preferences and the actual role that they perceived they had 
played in treatment-decision making (Table 4). These studies mainly 
focussed on patients with breast cancer (Bilodeau and Degner, 1996; Degner 
et al., 1997; Beaver et al., 1999; Wallberg et al., 2000; Keating et al., 2002) 
although one of these studies also incorporated patients with colorectal 
cancer (Beaver et al., 1999). Two studies focussed on patients with one of a 
range of cancer types (Barry and Henderson, 1996; Gattellari et al., 2001) 
and one study focussed on patients with lung cancer (Davidson et al., 1999). 
The findings from these studies revealed that there were no studies in which 
all patients who participated attained their role preference. In fact, in four of 
these studies, less than 50% of patients who participated attained their role 
preference (Degner et al., 1997; Beaver et al., 1999; Gattellari et al., 2001; 
Keating et al., 2002). However, researchers in one study (Beaver et al., 
1999) reported that 60% of the patients who had been diagnosed with 
colorectal cancer attained their role preference (12% more than in the breast 
cancer patient group in the same study) and a total of 72% of patients with 
breast cancer in another study (Wallberg et al., 2000) perceived that they 
played the role that they preferred. Three studies (Barry and Henderson, 
1996; Bilodeau and Degner, 1996; Degner et al., 1997) investigated which 
patients were most likely to achieve their role preferences. One team of 
researchers (Degner et al., 1997) identified that those women who had 
perceived that they had achieved their role preference were those who had 
preferred a passive role, whereas in another study (Bilodeau and Degner, 
1996), the researchers found that agreement was most evident between 
women who preferred an active role and who perceived that they had indeed 
achieved this role. A small scale pilot study (Barry and Henderson, 1996) of 
palliative patients (n =7) found that discrepancies between role preferences 
and role attainment increased with the progress of the disease with patients 




Four studies also investigated the degrees of congruence between patients’ 
own role preferences and their physicians of these preferences 
(Rothenbacher et al., 1997; Pyke Grimm et al., 1999; Bruera et al., 2001; 
Heyland et al., 2003). In all of these studies, agreement between patients 
and physicians, with respect to decision-making preferences, occurred in less 
than 50% of cases (Rothenbacher et al., 1997; Pyke Grimm et al., 1999; 
Bruera et al., 2001; Heyland et al., 2003). One team of researchers (Bruera 
et al., 2002) also identified that the degree of congruence between patients’ 
and physicians’ perceptions differed between categories of income and age, 
with patients of a higher income status and patients who were younger being 
closer to physicians perceptions of their patients’ decision-making 
preferences.  
Impact of role preferences on patient outcomes  
Three studies investigated whether the extent to which patients actually 
achieved their role preference in treatment decision making impacted upon 
patient outcomes, such as level of anxiety experienced and satisfaction with 
the consultation (Heyland et al., 2000; Keating et al., 2002; Janz et al., 
2004). One team of researchers (Heyland et al., 2000) found that patients 
who attained their role preference (34%) experienced significant decreases in 
anxiety from pre-consultation to immediate post-consultation, when com-
pared with those whose involvement was less than anticipated. They also 
identified that patients who attained their role preference were more likely to 
be satisfied with the consultation and patients who were less active than 
desired were more likely to be less satisfied (Heyland et al., 2000). 
Researchers (Keating et al., 2002), in a study involving over 1000 women 
with breast cancer, also reported that patients who attained their role 
preference (49%) were more likely to be satisfied with the treatment 
decision-making process. Another study (Janz et al., 2004), however, found 
that role preference in women with breast cancer (n =101) was not 
associated with greater levels of satisfaction with the treatment decision 
itself, but women who perceived that they had played a more active role in 
decision making were more likely to feel higher levels of satisfaction in 
general.  
Discussion  
Methodological concerns  
Despite the growing abundance of research in relation to preferences for 
involvement in treatment decision making amongst patients with cancer, 
there are a number of methodological limitations of this body of work worth 
noting. In particular, generalising from the 31 studies included in this review 
is problematic because of small sample sizes, the inability to decipher from 
reading these papers whether or not the sample is representative of a wider 
population and the wide variation in the characteristics of the study samples.  
Sample sizes were small in the majority of studies included in this review 
(only nine studies had recruited a patient group of 150 or more). This is a 
cause of concern for those studies that used statistical techniques to 
investigate relationships and correlations between variables (for example, 
preference for involvement in treatment decision making with age), since 
samples of less than 100 can produce misleading results. It is also impossible 
to assess from what was written in some papers about sampling and 
recruitment whether or not those patients sampled were representative of a 
larger group of the population. Yet, without this information it is not possible 
to assess whether findings can be generalised beyond the study sample. 
Moreover, most studies have either focussed on the preferences of women 
with breast cancer or have included a heterogeneous group of a mix of 
cancer types. The findings from studies focussing on patients with breast 
cancer, therefore, represent only a small subset of patients with cancer, 
whilst the inclusion of heterogeneous groups makes it impossible to 
determine how cancer type, stage of cancer, and indeed, treatment options, 
influence patients’ preferences for involvement in treatment decision making. 
Furthermore, little research has investigated the extent to which patients’ 
preferences vary by prognosis and severity of illness. These factors are often 
not considered as part of a systematic sampling strategy and hence, 
generalising the findings from a study of preferences for one group of 
patients with a specific type of cancer to another group of patients is 
inappropriate. Finally, largely missing from this body of research is 
investigations of preferences of palliative patients and those of teenagers and 
young people.  
 
Another reason why caution must be used in generalising from this body of 
evidence is because some studies examined patients’ perceptions of 
preferences for involvement in treatment decision making based on their 
recollections of the decision process. This may have been several months 
after the actual event, whereas other studies asked patients to recall their 
preferences much closer to the decision-making event. Other studies did not 
ask patients to recall, but rather used hypothetical examples. Although 
studies have varied in their sampling strategies, with some recruiting newly 
diagnosed patients, and others recruiting patients who may be considered in 
the survivorship period, or indeed in the palliative stages of their disease, it 
is not known the extent to which patients’ perceptions of their preferences 
for involvement is dependent on when they are asked to recall their 
preferences.  
 
The predominant method for assessing patients’ preferences for 
involvement in treatment decision making has largely involved the use of a 
preferences scale (Box 2). The reliability and validity of these scales is 
questionable, however, since a study by Entwistle (2001) found that it is 
difficult for patients to select an appropriate role description using such a 
scale. Furthermore, patients may choose conflicting role descriptions from 
the scale and patients may choose descriptions which may not necessarily 
correspond with their narrative descriptions about how their treatment 
decisions were made (Entwistle, 2001). Concern about a lack of consensus 
amongst patients and health care professionals about what the concepts of 
participation and involvement actually mean further compounds the problem 
with the reliability and validity of these scales. Subsequently, further 
research should investigate these points in conjunction with the use of these 
types of scales.  
Summary and gaps in evidence  
Although cross comparison of published studies about patients’ preferences 
for involvement in treatment decision making is problematic due to the 
limitations discussed above, the 31 studies included in this review show that 
patients’ preferences vary quite considerably. While most patients are likely 
to prefer a collaborative role, a significant minority prefer a passive role, 
followed by those who prefer an active role. Some studies have found that 
this minority can be quite substantial suggesting that making assumptions 
that patients wish to assume responsibility for treatment decision making is 
not necessarily wise.  
 
Some studies have investigated the association between factors such as, 
age, gender, race/ethnicity, education, level of income, marital status, 
employment status, socioeconomic status, type and stage of cancer and 
patients’ health status with role preferences in treatment decision making. 
However, the evidence to date is contradictory, meaning that the extent to 
which these factors influence patients’ preferences for involvement is 
unclear. Given the inconclusiveness of this evidence, it is not possible to 
predict which patients will prefer passive, active or collaborative roles in 
treatment decision making. Perhaps it is not surprising therefore, that 
physicians are not able to accurately predict patients’ preferences in most 
cases and there is no simple formula that they can use to facilitate accurate 
prediction of these. It seems, on balance, that predicting patients’ 
preferences may, therefore, be a wasted effort.  
 
Only a handful of studies have investigated the degree of congruence 
between patients’ role preferences and the actual role that they perceived 
themselves to have played in treatment decision making. This body of 
research suggests that whilst some patients do attain their role preference, 
there are many others who do not. Why some attain their role preference 
and others do not, however, has not been considered in any great detail. 
Furthermore, given the small numbers of studies that have investigated the 
impact of role preferences on outcomes such as, anxiety and patient 
satisfaction, it is not possible to confirm with certainty whether attaining role 
preferences, particularly active or passive roles, actually impacts on patients’ 
outcomes. It seems naive to assume therefore, that all patients will benefit 
from active involvement in treatment decision making.  
 
None of the studies included in this review examined patients’ preferences for 
involvement in treatment decision making over time. Yet, patients’ 
preferences may not be a static or one-off event but instead, may be a 
dynamic and longitudinal process for the following reasons; patients may 
prefer to adopt a passive role within the first few months following diagnosis, 
but prefer a more active role during the course of their illness or vice versa, 
preferences may change in relation to the stage of their disease and the 
seriousness of their condition, and preferences may vary according to the 
specific treatment decision that patients are required to consider. Whether 
and how preferences change over the patient journey warrants further 
research.  
 
Limitations of the review  
Whilst we are confident that the electronic searches identified relevant 
studies we did not give enough time to hand searching in all relevant 
journals, which means that some relevant papers may have been overlooked. 
Moreover, this review does not represent the complete body of research 
since we only included papers published between 1994 and 2004 and there 
has been some seminal research about preferences for involvement in 
treatment decision making carried out prior to 1994 (Cassileth et al., 1980; 
Degner and Sloan, 1992). Finally, whereas this is a narrative review of the 
evidence, which is a descriptive account of the data about preferences for 
involvement in treatment decision making, a meta-analysis of some of the 
studies included here, particularly those that have similar samples and which 
use the same preferences scale, could also provide some useful insight about 
patients’ preferences.  
Conclusions  
Changes in societal attitudes towards patient involvement in treatment 
decision making coupled with a much more consumerist and citizenship 
approach to health care is likely to affect medical practice. Those 
recommending increasing involvement of patients in treatment decision 
making have asserted that most patients prefer a collaborative role and that 
this leads to improved satisfaction with the consultation and decision-making 
process. Yet, this assertion is not confirmed by most of the empirical work 
conducted thus far. Evidence about patients’ preferred level of involvement in 
treatment decision making, the factors that influence their level of 
involvement, the degree of congruence between their preferred and actual 
roles in treatment decision making and the impact of their involvement on 
patient outcomes is not compelling. More rigorous investigations are required 
before recommendations for health care professionals can be processed with 
full confidence. It is with this proviso in mind that we conclude by making the 
following recommendations for health professionals in relation to patients’ 
involvement in treatment decision making which stand in the face of the 
limited current evidence base.  
 
Given that patients vary in their preferences for involvement in treatment 
decision making, it is important that health care professionals identify 
individual decision-making preferences, rather than advocate participation or 
non-participation for all patients. To deliver patient-centred care that 
privileges the needs of the patient above those of the system, health 
professionals should assess each patient individually and acknowledge that 
preferences are likely to change over time and with the influence of many 
factors. Thus, assessing preferences for involvement is not a onetime event 
but rather, a process that should be conducted throughout the duration of 
the patients’ cancer journey. Finally, there is no formula for predicting 
patients’ preferences and so possibly, the easiest way to find out about 
patients’ preferences for involvement in treatment decision making is simply 
by asking them.  
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